Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2019 3
2020 3
2021 6
2022 2
2023 6
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain.
Puig T, Leache L, González-Senac NM, Carreras E, Gutiérrez-Valencia M, Losa L, Revuelta-Herrero JL, Marrero-Álvarez P, de Miguel M, Aguirrezabal Arredondo A, Aranguren A, Vilariño A, Ruiz VE, Fernández I, Bilbao J, González-Guerrero C, Del Pino B, Garin N; MAPAC-MPC Network. Puig T, et al. BMC Geriatr. 2024 Sep 30;24(1):798. doi: 10.1186/s12877-024-05308-3. BMC Geriatr. 2024. PMID: 39350081 Free PMC article.
Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review.
Salazar J, Bracchiglione J, Savall-Esteve O, Antequera A, Bottaro-Parra D, Gutiérrez-Valencia M, Martínez-Peralta S, Pericay C, Tibau A, Bonfill X; Appropriateness of Systemic Oncological Treatments for Advanced Cancer (ASTAC) Research Group. Salazar J, et al. BMC Cancer. 2023 Aug 12;23(1):748. doi: 10.1186/s12885-023-11207-4. BMC Cancer. 2023. PMID: 37573294 Free PMC article.
Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map.
Salazar J, Bracchiglione J, Acosta-Dighero R, Meza N, Meade AG, Quintana MJ, Requeijo C, Rodríguez-Grijalva G, Santero M, Selva A, Solà I, Bonfill X; Appropriateness of Systemic Oncological Treatments for Advanced Cancer (ASTAC) Research Group. Salazar J, et al. Among authors: requeijo c. Support Care Cancer. 2023 Jan 9;31(2):100. doi: 10.1007/s00520-022-07564-8. Support Care Cancer. 2023. PMID: 36622453 Free PMC article.
Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map.
Requeijo C, Bracchiglione J, Meza N, Acosta-Dighero R, Salazar J, Santero M, Meade AG, Quintana MJ, Rodríguez-Grijalva G, Selva A, Solà I, Urrútia G, Bonfill Cosp X; Appropriateness of Systemic Oncological Treatments for Advanced Cancer (ASTAC) Research Group. Requeijo C, et al. Clin Epidemiol. 2023 Nov 10;15:1069-1085. doi: 10.2147/CLEP.S431498. eCollection 2023. Clin Epidemiol. 2023. PMID: 38025841 Free PMC article. Review.
Systemic Oncological Treatments versus Supportive Care for Patients with Advanced Hepatobiliary Cancers: An Overview of Systematic Reviews.
Bracchiglione J, Rodríguez-Grijalva G, Requeijo C, Santero M, Salazar J, Salas-Gama K, Meade AG, Antequera A, Auladell-Rispau A, Quintana MJ, Solà I, Urrútia G, Acosta-Dighero R, Bonfill Cosp X. Bracchiglione J, et al. Among authors: requeijo c. Cancers (Basel). 2023 Jan 26;15(3):766. doi: 10.3390/cancers15030766. Cancers (Basel). 2023. PMID: 36765723 Free PMC article. Review.
Effectiveness of nonpharmacological interventions to prevent adverse events in the intensive care unit: A review of systematic reviews.
Suclupe S, Efrain Pantoja Bustillos P, Bracchiglione J, Requeijo C, Salas-Gama K, Solà I, Merchán-Galvis A, Uya Muntaña J, Robleda G, Martinez-Zapata MJ. Suclupe S, et al. Among authors: requeijo c. Aust Crit Care. 2023 Sep;36(5):902-914. doi: 10.1016/j.aucc.2022.11.003. Epub 2022 Dec 24. Aust Crit Care. 2023. PMID: 36572576 Free article. Review.
Efficacy of systemic oncological treatments in patients with advanced pancreatic cancer at high risk of dying in the short or medium-term: overview of systematic reviews.
Salazar J, Pérez-Bracchiglione J, Salas-Gama K, Antequera A, Auladell-Rispau A, Dorantes-Romandía R, Meade AG, Jesús Quintana M, Requeijo C, Rodríguez-Grijalva G, Santero M, Acosta-Dighero R, Solà I, Urrútia G, Bonfill Cosp X; Systemic Treatments for Advanced Digestive Cancer Research. Salazar J, et al. Among authors: requeijo c. Eur J Cancer. 2021 Sep;154:82-91. doi: 10.1016/j.ejca.2021.05.034. Epub 2021 Jul 9. Eur J Cancer. 2021. PMID: 34252759
SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose-lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: A systematic review.
Escobar C, Barrios V, Cosín J, Gámez Martínez JM, Huelmos Rodrigo AI, Ortíz Cortés C, Torres Llergo J, Requeijo C, Solà I, Martínez Zapata MJ. Escobar C, et al. Among authors: requeijo c. Diabet Med. 2021 Mar;38(3):e14502. doi: 10.1111/dme.14502. Epub 2021 Jan 4. Diabet Med. 2021. PMID: 33368612
Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term: an overview of systematic reviews.
Santero M, Pérez-Bracchiglione J, Acosta-Dighero R, Meade AG, Antequera A, Auladell-Rispau A, Quintana MJ, Requeijo C, Rodríguez-Grijalva G, Salas-Gama K, Dorantes-Romandia R, Salazar J, Solà I, Urrútia G, Bonfill Cosp X. Santero M, et al. Among authors: requeijo c. BMC Cancer. 2021 Jun 16;21(1):712. doi: 10.1186/s12885-021-08330-5. BMC Cancer. 2021. PMID: 34134661 Free PMC article. Review.
24 results